AIM ImmunoTech to Present at the H.C. Wainwright 22nd Annual Global Investment Conference on September 14th
AIM ImmunoTech Inc. (NYSE American:AIM) will present at the H.C.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
AIM ImmunoTech Inc. (NYSE American:AIM) will present at the H.C. Wainwright Annual Global Investment Conference from September 14-16, 2020. CEO Thomas K. Equels is set to deliver a presentation on September 14 at 5:00 p.m. ET, which will be available via live webcast. The company focuses on developing therapeutics for various cancers, immune disorders, and viral diseases, including COVID-19.
Details
News Market Reaction – AIM
The recorded move for AIM in the trading session of this news was -3.66%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
OCALA, FL / ACCESSWIRE / September 10, 2020 / AIM ImmunoTech Inc. (NYSE American:AIM) today announced that the company will be presenting at the H.C. Wainwright Annual Global Investment Conference, being held virtually on September 14-16, 2020.
Thomas K. Equels, Chief Executive Officer of AIM ImmunoTech, is scheduled to present on Monday, September 14 at 5:00 p.m., Eastern Time. The presentation will be webcast live on the conference event platform, which can be accessed here.
About AIM ImmunoTech Inc.
AIM ImmunoTech Inc. is an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders and viral diseases, including COVID-19, the disease caused by the SARS-CoV-2 virus.
Contacts:
Crescendo Communications, LLC
Phone: 212-671-1021
Email: aim@crescendo-ir.com
AIM ImmunoTech Inc
Phone: 800-778-4042
Email: IR@aimimmuno.com
SOURCE: AIM ImmunoTech Inc.
View source version on accesswire.com:
https://www.accesswire.com/605463/AIM-ImmunoTech-to-Present-at-the-HC-Wainwright-22nd-Annual-Global-Investment-Conference-on-September-14th
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.